Elligo Health Research announced a partnership with Avallano to launch myTrialsConnectSM a scalable research community powered by artificial intelligence (AI), that was built to serve patients, providers, sites, and the biopharma industry.
Patients can join through a variety of means including social media, as part of a clinical trial or as a patient in a healthcare provider’s network. As a member, they receive a copy of their full medical record, educational materials that are oriented to their particular interest and conditions, and customized messages. Messages will alert patients when they are eligible for a particular clinical trial based on an automated review of their medical records and chatbot-based surveys, which gather additional information (such as social determinants of health) that are not typically found in the medical record.
For providers, myTrialsConnectSM will offer information and services directly to healthcare providers by giving them a 360-degree view of their patients’ entire medical journey and by providing an open and direct communication channel that can be customized to serve the interests of each provider’s unique patient population.
For the biopharmaceutical industry, myTrialsConnectSM creates a virtual waiting room of patients who have been qualified via medical records and additional protocol-specific data not found in electronic health records (EHRs), and who have seen a description of the study and expressed their interest in participating. This removes two of the biggest delays in getting patients into trials — the time to fully qualify them and the need to find patients that want to participate.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!